Promoting psycho-social wellbeing for engaging inflammatory bowel disease patients in their care: an Italian consensus statement.

IBD Patient engagement Psychological needs Psychological support Quality of life

Journal

BMC psychology
ISSN: 2050-7283
Titre abrégé: BMC Psychol
Pays: England
ID NLM: 101627676

Informations de publication

Date de publication:
28 Nov 2021
Historique:
received: 03 06 2021
accepted: 11 11 2021
entrez: 29 11 2021
pubmed: 30 11 2021
medline: 1 12 2021
Statut: epublish

Résumé

Inflammatory bowel diseases (IBD) are remitting and relapsing diseases that mainly interest the gastrointestinal tract. IBD is associated with a condition of psycho-social discomfort that deeply compromises the quality of life and the competence of patient to be fully engaged in their self-management. As a consequence, effective care of IBD patients should include not only medical but also psychological support in order to improve patients' wellbeing. Although this, to date there is no standardized approach to promote psychological wellbeing of IBD patients in order to improve the perception of the quality of the care. To fill this gap, a consensus conference has been organized in order to define the psychosocial needs of IBD patients and to promote their engagement in daily clinical practice. This paper describes the process implemented and illustrates the recommendations deriving from it, which focus on the importance of a multidisciplinary approach in IBD management. The consensus conference has been organized in three phases: (1) literature review about life experiences, engagement, and psychosocial needs of IBD patients; (2) workshops with IBD experts and patients' representatives; (3) drafting of statements and voting. Seventy-three participants were involved in the consensus conference, and sixteen statements have been voted and approved during the consensus process. The main conclusion is the necessity of the early detection of - and, in case of need, intervention on- psycho-social needs of patients in order to achieve patient involvement in IBD care.

Sections du résumé

BACKGROUND BACKGROUND
Inflammatory bowel diseases (IBD) are remitting and relapsing diseases that mainly interest the gastrointestinal tract. IBD is associated with a condition of psycho-social discomfort that deeply compromises the quality of life and the competence of patient to be fully engaged in their self-management. As a consequence, effective care of IBD patients should include not only medical but also psychological support in order to improve patients' wellbeing. Although this, to date there is no standardized approach to promote psychological wellbeing of IBD patients in order to improve the perception of the quality of the care. To fill this gap, a consensus conference has been organized in order to define the psychosocial needs of IBD patients and to promote their engagement in daily clinical practice. This paper describes the process implemented and illustrates the recommendations deriving from it, which focus on the importance of a multidisciplinary approach in IBD management.
RESULTS RESULTS
The consensus conference has been organized in three phases: (1) literature review about life experiences, engagement, and psychosocial needs of IBD patients; (2) workshops with IBD experts and patients' representatives; (3) drafting of statements and voting. Seventy-three participants were involved in the consensus conference, and sixteen statements have been voted and approved during the consensus process.
CONCLUSIONS CONCLUSIONS
The main conclusion is the necessity of the early detection of - and, in case of need, intervention on- psycho-social needs of patients in order to achieve patient involvement in IBD care.

Identifiants

pubmed: 34839834
doi: 10.1186/s40359-021-00692-6
pii: 10.1186/s40359-021-00692-6
pmc: PMC8628380
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

186

Informations de copyright

© 2021. The Author(s).

Références

Inflamm Bowel Dis. 2019 Jan 1;25(1):204-212
pubmed: 29992302
Behav Res Ther. 2004 Apr;42(4):367-83
pubmed: 14998732
Inflamm Bowel Dis. 2006 Jan;12(1):70-3
pubmed: 16374262
Scand J Gastroenterol. 1996 Aug;31(8):792-6
pubmed: 8858749
World J Gastroenterol. 2007 Jan 21;13(3):438-43
pubmed: 17230615
Recenti Prog Med. 2017 Nov;108(11):455-475
pubmed: 29149163
Soc Sci Med. 1985;21(2):115-20
pubmed: 4048997
Inflamm Bowel Dis. 2017 Jan;23(1):89-96
pubmed: 28002128
Inflamm Bowel Dis. 2012 Jul;18(7):1232-9
pubmed: 22234954
PLoS One. 2017 Feb 10;12(2):e0171864
pubmed: 28187201
BMJ Open. 2019 Apr 20;9(4):e025568
pubmed: 31005923
Inflamm Bowel Dis. 2011 Feb;17(2):590-8
pubmed: 20848545
Inflamm Bowel Dis. 2011 Oct;17(10):E131-2
pubmed: 21739535
Trials. 2015 Jun 16;16:271
pubmed: 26073770
J Health Polit Policy Law. 1988 Fall;13(3):469-98
pubmed: 3171113
Inflamm Bowel Dis. 2006 Aug;12(8):697-707
pubmed: 16917224
J Psychosom Res. 2016 Aug;87:70-80
pubmed: 27411754
Health Aff (Millwood). 2013 Feb;32(2):207-14
pubmed: 23381511
J Paediatr Child Health. 2015 Mar;51(3):266-70
pubmed: 25039307
Br J Med Med Res. 2016;12(3):
pubmed: 28217532
Inflamm Bowel Dis. 2016 Sep;22(9):2134-48
pubmed: 27542131
Health Serv Res. 2004 Aug;39(4 Pt 1):1005-26
pubmed: 15230939
Aliment Pharmacol Ther. 2015 Jul;42(2):203-11
pubmed: 25989464
Arch Dis Child. 2001 Mar;84(3):205-11
pubmed: 11207164
Expert Rev Gastroenterol Hepatol. 2009 Dec;3(6):661-79
pubmed: 19929586
Inflamm Bowel Dis. 2010 Apr;16(4):657-63
pubmed: 19714755
Inflamm Bowel Dis. 2016 May;22(5):1151-6
pubmed: 27070910
Inflamm Bowel Dis. 2013 Nov;19(12):2704-15
pubmed: 23846488
Digestion. 2015;91(3):239-47
pubmed: 25823689
Nat Clin Pract Gastroenterol Hepatol. 2006 Aug;3(8):416-7
pubmed: 16883327
Gastroenterol Clin North Am. 2017 Dec;46(4):745-767
pubmed: 29173519
BMC Gastroenterol. 2021 Jul 14;21(1):293
pubmed: 34261434
J Adolesc Health. 2015 Aug;57(2):212-7
pubmed: 26206442
Lancet Gastroenterol Hepatol. 2020 Jul;5(7):631-632
pubmed: 32411920
J Adolesc Health. 1993 Nov;14(7):570-6
pubmed: 8312295
Pol Przegl Chir. 2017 Aug 31;89(4):16-22
pubmed: 28905800
J Psychosom Res. 2019 Jan;116:44-53
pubmed: 30654993
Health Commun. 2017 Dec;32(12):1529-1538
pubmed: 27819486
Int J Behav Med. 2018 Oct;25(5):517-525
pubmed: 30159665
Ann Gastroenterol. 2017;30(1):89-95
pubmed: 28042243
Inflamm Bowel Dis. 2017 Mar;23(3):357-365
pubmed: 28221247
Expert Rev Pharmacoecon Outcomes Res. 2015 Apr;15(2):253-66
pubmed: 25656310
J Thorac Dis. 2018 Mar;10(Suppl 4):S517-S528
pubmed: 29629198
Inflamm Bowel Dis. 2018 Apr 23;24(5):960-965
pubmed: 29688469
Indian J Gastroenterol. 2018 Jul;37(4):284-292
pubmed: 30209778
Clin Epidemiol. 2018 Sep 25;10:1289-1305
pubmed: 30310323
Am J Gastroenterol. 1999 Mar;94(3):697-703
pubmed: 10086654
Qual Life Res. 2010 Dec;19(10):1487-500
pubmed: 20668950
Inflamm Bowel Dis. 2009 Jul;15(7):1105-18
pubmed: 19161177
Scand J Caring Sci. 2016 Dec;30(4):678-686
pubmed: 26395446
J Med Internet Res. 2017 Dec 06;19(12):e402
pubmed: 29212630
Frontline Gastroenterol. 2017 Oct;8(4):272-278
pubmed: 29067153
Dig Liver Dis. 2017 Dec;49(12):1320-1326
pubmed: 28899622
Inflamm Bowel Dis. 2015 Jul;21(7):1641-51
pubmed: 25966837
Nat Rev Gastroenterol Hepatol. 2017 Mar;14(3):133-134
pubmed: 28119535
Inflamm Bowel Dis. 2011 Sep;17(9):1882-9
pubmed: 21830266
Inflamm Bowel Dis. 2006 Dec;12(12):1175-84
pubmed: 17119392
Gastroenterol Nurs. 2018 Jan/Feb;41(1):19-28
pubmed: 29373352
Can J Gastroenterol. 2012 Aug;26(8):525-31
pubmed: 22891177
Nat Rev Gastroenterol Hepatol. 2015 Mar;12(3):133-46
pubmed: 25645969
Child Care Health Dev. 2012 Mar;38(2):273-9
pubmed: 21299591
Ann Intern Med. 2018 Oct 2;169(7):467-473
pubmed: 30178033
Gastroenterol Nurs. 2018 Jul/Aug;41(4):333-340
pubmed: 28759516
J Crohns Colitis. 2014 Oct;8(10):1281-6
pubmed: 24662394
J Pediatr Nurs. 2018 Jan - Feb;38:106-113
pubmed: 29357985
J Am Acad Child Adolesc Psychiatry. 2007 Oct;46(10):1290-1298
pubmed: 17885570
Cochrane Database Syst Rev. 2016 Apr 29;4:CD009794
pubmed: 27128768
Eur Rev Med Pharmacol Sci. 2015 Aug;19(15):2838-51
pubmed: 26241538
Curr Drug Targets. 2014;15(11):1020-9
pubmed: 24975400
BMJ Open Gastroenterol. 2016 Mar 02;3(1):e000071
pubmed: 26966551
Inflamm Bowel Dis. 2016 Jan;22(1):164-70
pubmed: 26383912
J Spec Pediatr Nurs. 2011 Jul;16(3):207-15
pubmed: 21702881
JMIR Res Protoc. 2018 Dec 21;7(12):e190
pubmed: 30578197
Patient Prefer Adherence. 2016 Nov 23;10:2387-2396
pubmed: 27920505
Eur J Gastroenterol Hepatol. 2016 Sep;28(9):1056-64
pubmed: 27286569
Neuro Endocrinol Lett. 2016 Oct;37(5):395-402
pubmed: 28231685
J Crohns Colitis. 2013 Jun;7(5):355-68
pubmed: 22503168
Lancet. 2017 Apr 29;389(10080):1741-1755
pubmed: 27914655
Dig Dis Sci. 2011 Oct;56(10):2972-7
pubmed: 21538016
J Pediatr. 2017 May;184:94-100.e1
pubmed: 28238483
Obes Surg. 2005 Apr;15(4):546-51
pubmed: 15946436
Clin Exp Gastroenterol. 2016 Mar 07;9:49-58
pubmed: 27022294
Am J Manag Care. 2009 Jun;15(6):353-60
pubmed: 19514801
World J Gastroenterol. 2017 May 28;23(20):3624-3631
pubmed: 28611515
Med Decis Making. 1997 Jul-Sep;17(3):353-4
pubmed: 9219198
J Pediatr Psychol. 2010 Sep;35(8):857-69
pubmed: 20123705
EBioMedicine. 2015 Aug 08;2(9):1251-6
pubmed: 26501125
J Crohns Colitis. 2013 Dec;7(12):935-49
pubmed: 23466412
Inflamm Bowel Dis. 2011 Jan;17(1):423-39
pubmed: 20564651
Inflamm Bowel Dis. 2017 Dec 19;24(1):179-190
pubmed: 29272489
Qual Health Care. 1999 Dec;8(4):247-52
pubmed: 10847887
United European Gastroenterol J. 2019 Jul;7(6):767-781
pubmed: 31316781
Frontline Gastroenterol. 2011 Oct;2(4):237-241
pubmed: 28839617
J Pediatr Gastroenterol Nutr. 2016 Dec;63(6):658-664
pubmed: 27035372
Frontline Gastroenterol. 2015 Oct;6(4):290-297
pubmed: 28839825
Aliment Pharmacol Ther. 2013 Jan;37(2):195-203
pubmed: 23151246
JGH Open. 2019 Aug 02;4(2):166-171
pubmed: 32280760
J Am Acad Child Adolesc Psychiatry. 2004 Dec;43(12):1469-77
pubmed: 15564816
Health Qual Life Outcomes. 2004 Sep 27;2:55
pubmed: 15450120
Clin J Sport Med. 2007 Sep;17(5):384-8
pubmed: 17873551
BMJ. 1999 Jan 30;318(7179):318-22
pubmed: 9924064
Neuropsychiatr Dis Treat. 2016 Mar 23;12:665-72
pubmed: 27042077
Curr Gastroenterol Rep. 2020 Feb 10;22(3):12
pubmed: 32040650
Eur J Gastroenterol Hepatol. 2014 Sep;26(9):964-71
pubmed: 25003746
JAMA Pediatr. 2013 Oct;167(10):897-9
pubmed: 23959327
Patient Prefer Adherence. 2018 Aug 27;12:1579-1586
pubmed: 30214160
J Pediatr Psychol. 2018 May 1;43(4):413-422
pubmed: 29048552

Auteurs

Guendalina Graffigna (G)

EngageMindsHUB, Università Cattolica del Sacro Cuore Milan, Milan, Italy.

Caterina Bosio (C)

EngageMindsHUB, Università Cattolica del Sacro Cuore Milan, Milan, Italy. Caterina.bosio@unicatt.it.

Francesco Pagnini (F)

EngageMindsHUB, Università Cattolica del Sacro Cuore Milan, Milan, Italy.

Eleonora Volpato (E)

EngageMindsHUB, Università Cattolica del Sacro Cuore Milan, Milan, Italy.

Enrica Previtali (E)

Amici Onlus, Milan, Italy.

Salvatore Leone (S)

Amici Onlus, Milan, Italy.

Ferdinando D'Amico (F)

Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.

Alessandro Armuzzi (A)

Fondazione Policlinico Universitario A. Gemelli IRCS, Rome, Italy.

Silvio Danese (S)

Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
IBD Center, Humanitas Research Hospital- IRCCS, Rozzano, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH